CRBU

CARIBOU BIOSCIENCES INC

Healthcare | Micro Cap

-$0.30

EPS Forecast

$2.58

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.30

Revenue Forecast:

$2.58

EPS Surprise Forecast:

$0.037

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±8.6%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

53%

Probability of beating both EPS & revs consensus:

37%

Probability of missing both EPS & revs consensus:

25%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.14

Revenue standard deviation:

$5

As % of share price:

6.90%

As % of market cap:

2.77% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.14

Revenue 95th %ile:

$9

EPS 75th %ile:

-$0.25

Revenue 75th %ile:

$4

EPS 25th %ile:

-$0.34

Revenue 25th %ile:

$1

EPS 5th %ile:

-$0.47

Revenue 5th %ile:

-$3

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

36% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

90% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$90

Bid-ask per Share:

$0.02